Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 6
2001 6
2002 4
2003 4
2004 9
2005 9
2006 14
2007 10
2008 8
2009 7
2010 6
2011 5
2012 4
2013 4
2014 7
2015 5
2016 4
2017 3
2019 2
2020 3
2021 2
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.
Pérez-García JM, Gebhart G, Ruiz Borrego M, Stradella A, Bermejo B, Schmid P, Marmé F, Escrivá-de-Romani S, Calvo L, Ribelles N, Martinez N, Albacar C, Prat A, Dalenc F, Kerrou K, Colleoni M, Afonso N, Di Cosimo S, Sampayo-Cordero M, Malfettone A, Cortés J, Llombart-Cussac A; PHERGain steering committee and trial investigators. Pérez-García JM, et al. Among authors: kerrou k. Lancet Oncol. 2021 Jun;22(6):858-871. doi: 10.1016/S1470-2045(21)00122-4. Epub 2021 May 18. Lancet Oncol. 2021. PMID: 34019819 Clinical Trial.
[Functional chest imaging].
Carette MF, Kerrou K, Khalil A. Carette MF, et al. Among authors: kerrou k. Rev Pneumol Clin. 2005 Oct;61(5 Pt 1):291-5. doi: 10.1016/s0761-8417(05)84842-4. Rev Pneumol Clin. 2005. PMID: 16292153 Review. French. No abstract available.
[PET in thyroid cancers].
Talbot JN, Montravers F, Younsi N, Zanotti-Fregonara P, Grahek D, Kerrou K, Gutman F, Périé S, Maurel G, Saint Guily JL, Devaux JY, Duron F. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1377-85. doi: 10.1016/s0755-4982(06)74821-7. Presse Med. 2006. PMID: 16969334 Review. French.
[PET and malignant cerebral tumors].
Talbot JN, Kerrou K, Gault N, Gutman F, Grahek D, Touboul E, Schlienger M, Montravers F. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1347-53. doi: 10.1016/s0755-4982(06)74818-7. Presse Med. 2006. PMID: 16969331 Review. French.
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.
Gligorov J, Benderra MA, Barthere X, de Forceville L, Antoine EC, Cottu PH, Delaloge S, Pierga JY, Belkacemi Y, Houvenaegel G, Pujol P, Rivera S, Spielmann M, Penault-Llorca F, Namer M; et l'ensemble des experts des votes des RPC Saint-Paul 2022-2023. Gligorov J, et al. Bull Cancer. 2023 Nov;110(10S):10S1-10S43. doi: 10.1016/S0007-4551(23)00473-3. Bull Cancer. 2023. PMID: 38061827
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
Pérez-García JM, Cortés J, Ruiz-Borrego M, Colleoni M, Stradella A, Bermejo B, Dalenc F, Escrivá-de-Romaní S, Calvo Martínez L, Ribelles N, Marmé F, Cortés A, Albacar C, Gebhart G, Prat A, Kerrou K, Schmid P, Braga S, Di Cosimo S, Gion M, Antonarelli G, Popa C, Szostak E, Alcalá-López D, Gener P, Rodríguez-Morató J, Mina L, Sampayo-Cordero M, Llombart-Cussac A; PHERGain Trial Investigators. Pérez-García JM, et al. Among authors: kerrou k. Lancet. 2024 Apr 27;403(10437):1649-1659. doi: 10.1016/S0140-6736(24)00054-0. Epub 2024 Apr 3. Lancet. 2024. PMID: 38582092 Clinical Trial.
Neglected giant benign phyllode tumor of the breast.
Benderra MA, Ferrier C, Buob D, Gligorov J, Kerrou K. Benderra MA, et al. Among authors: kerrou k. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3954-3955. doi: 10.1007/s00259-022-05840-7. Epub 2022 May 18. Eur J Nucl Med Mol Imaging. 2022. PMID: 35583825 Free PMC article. No abstract available.
[Positron emission tomography (PET) in gastrointestinal cancer].
Montravers F, Grahek D, Kerrou K, Gutman F, Talbot JN. Montravers F, et al. Among authors: kerrou k. Gastroenterol Clin Biol. 2006 May;30(5):737-41. doi: 10.1016/s0399-8320(06)73306-1. Gastroenterol Clin Biol. 2006. PMID: 16801895 Free article. Review. French. No abstract available.
122 results